{"url":"https://lda.senate.gov/api/v1/filings/4f0c8fe6-6efd-4d8e-855d-a4dc65299a22/","filing_uuid":"4f0c8fe6-6efd-4d8e-855d-a4dc65299a22","filing_type":"RR","filing_type_display":"Registration","filing_year":2019,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/4f0c8fe6-6efd-4d8e-855d-a4dc65299a22/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Gary Heimberg","dt_posted":"2019-07-18T16:40:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"850 10th Street, NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":11195,"url":"https://lda.senate.gov/api/v1/registrants/11195/","house_registrant_id":31827,"name":"COVINGTON & BURLING LLP","description":"Law firm","address_1":"850 10th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS XENAKIS","contact_telephone":"+1 202-662-5846","dt_updated":"2026-07-29T10:42:26.460623-04:00"},"client":{"id":115327,"url":"https://lda.senate.gov/api/v1/clients/115327/","client_id":1006117,"name":"BEIGENE USA, INC.","general_description":"Biopharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-06-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Support anticipated first U.S. product launch and efforts to enhance company profile/reputation","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":62928,"prefix":null,"prefix_display":null,"first_name":"GARY","nickname":null,"middle_name":null,"last_name":"HEIMBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"BEIGENE, LTD.","contribution":"0.00","ownership_percentage":"100.00","address":"94 Solaris Avenue, Camana Bay, PO Box 1348","city":"Grand Cayman, KY1-1108","state":null,"state_display":null,"country":"KY","country_display":"Cayman Islands","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"KY","ppb_country_display":"Cayman Islands"}],"affiliated_organizations":[]}